The DOI matches its Crossref record; 97 of the 97 references it cites were found in a registry or an index.
Hepatitis B vaccination: The key towards elimination and eradication of hepatitis B
Open accessAbstract
Hepatitis B virus infection is a global health problem. Worldwide, about 360 million people are chronically infected with the virus. They continue to spread the virus to others and are themselves at risk of chronic liver diseases and hepatocellular carcinoma. The infection can now be treated by antivirals or interferons and the transmission route can be interrupted. Nevertheless, the most effective means is to immunize all susceptible individuals, especially young children, with safe and efficacious vaccines. The combined efforts of vaccination, effective treatment and interruption of transmission make elimination of the infection plausible and may eventually lead to eradication of the virus. Because hepatitis B vaccination has a key role in the control of hepatitis B, properties of this vaccine, its effectiveness in pre-exposure and post-exposure settings, duration of protection after vaccination and the need of booster doses are discussed. Mass hepatitis B vaccination in children decreases the carriage of the virus, and the diseases associated with acute and chronic infection, including hepatocellular carcinoma. Challenges that need to be solved to expand mass vaccination, and the strategies towards elimination and eventual eradication of hepatitis B in the world are also discussed.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Barré-Sinoussi, F., Chermann, J. C., Rey, F., Nugeyre, M. T., Chamaret, S., Gruest, J., Dauguet, C., Axler-Blin, C., Vézinet-Brun, F., Rouzioux, C., et al. (1983) · Science · doi:10.1126/science.6189183 · Cited by 7,038
Haine, M. M.-L., & Meeùs, N. (1986) · Cited by 3,464
Chang, M.-H., Chen, C.-J., Lai, M.-S., Hsu, H.-M., Wu, T.-C., Kong, M.-S., Liang, D.-C., Shau, W.-Y., & Chen, D.-S. (1997) · New England Journal of Medicine · doi:10.1056/nejm199706263362602 · Cited by 1,883 · cited 1×
“13/10(5) in those born after the program [129].”
BackgroundSelf-citationSzmuness, W., Stevens, C. E., Harley, E. J., Zang, E. A., Oleszko, W. R., William, D. C., Sadovsky, R., Morrison, J. M., & Kellner, A. (1980) · New England Journal of Medicine · doi:10.1056/nejm198010093031501 · Cited by 1,100
Vaccine-induced escape mutant of hepatitis B virus
Carman, W. F., Karayiannis, P., Waters, J., Thomas, H. C., Zanetti, A. R., Manzillo, G., & Zuckerman, A. J. (1990) · The Lancet · doi:10.1016/0140-6736(90)91874-a · Cited by 1,074
Beasley, R. P., CHIN-YUN LEE, G., Roan, C.-H., Hwang, L.-Y., Lan, C.-C., Huang, F.-Y., & Chen, C.-L. (1983) · The Lancet · doi:10.1016/s0140-6736(83)90624-4 · Cited by 813
Global control of hepatitis B virus infection
Kao, J.-H., & Chen, D.-S. (2002) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(02)00315-8 · Cited by 805
Self-citationManagement of hepatitis B: Summary of a clinical research workshop†
Hoofnagle, J. H., Doo, E., Liang, T. J., Fleischer, R., & Lok, A. S. F. (2007) · Hepatology · doi:10.1002/hep.21627 · Cited by 628
GYNAECOLOGISTS' ATTITUDES TO ABORTION
Savage, W., & Francome, C. (1989) · The Lancet · doi:10.1016/s0140-6736(89)91922-3 · Cited by 604
NEWCOMBE, R. (1975) · The Lancet · doi:10.1016/s0140-6736(75)90482-1 · Cited by 546
Shouval, D. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00152-1 · Cited by 470
Alter, M. J. (1990) · JAMA · doi:10.1001/jama.263.9.1218 · Cited by 458
Hepatitis B Vaccine in Patients Receiving Hemodialysis: Immunogenicity and Efficacy
Stevens, C. E., Alter, H. J., Taylor, P. E., Zang, E. A., Harley, E. J., Szmuness, W., & the Dialysis Vaccine Trial Study Group (1984) · New England Journal of Medicine · doi:10.1056/nejm198408233110803 · Cited by 457
FRANCIS, D. P., HADLER, S. C., THOMPSON, S. E., MAYNARD, J. E., OSTROW, D. G., ALTMAN, N., BRAFF, E. H., O'MALLEY, P., HAWKINS, D., JUDSON, F. N., et al. (1982) · Annals of Internal Medicine · doi:10.7326/0003-4819-97-3-362 · Cited by 428
The influence of age on the development of the hepatitis B carrier state
(1993) · Proceedings of the Royal Society of London. Series B: Biological Sciences · doi:10.1098/rspb.1993.0102 · Cited by 424
Antiretrovirals for reducing the risk of mother-to-child transmission of HIV infection
Volmink, J., Siegfried, N., van der Merwe, L., & Brocklehurst, P. (2007) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003510.pub2 · Cited by 396
West, D. (1996) · Vaccine · doi:10.1016/0264-410x(96)00062-x · Cited by 375
Zanetti, A. R., Mariano, A., Romanò, L., D'Amelio, R., Chironna, M., Coppola, R. C., Cuccia, M., Mangione, R., Marrone, F., Negrone, F. S., et al. (2005) · The Lancet · doi:10.1016/s0140-6736(05)67568-x · Cited by 368
Ni, Y., Huang, L., Chang, M., Yen, C., Lu, C., You, S., Kao, J., Lin, Y., Chen, H., Hsu, H., et al. (2007) · Gastroenterology · doi:10.1053/j.gastro.2007.02.055 · Cited by 348
Self-citationChen, D.-S. (1987) · JAMA: The Journal of the American Medical Association · doi:10.1001/jama.1987.03390190075023 · Cited by 333
Self-citationFrom Hepatitis to Hepatoma: Lessons from Type B Viral Hepatitis
Chen, D.-S. (1993) · Science · doi:10.1126/science.8211155 · Cited by 325
Self-citationRisk of anaphylaxis after vaccination of children and adolescents.
Bohlke, K., Davis, R. L., Marcy, S. M., Braun, M. M., DeStefano, F., Black, S. B., Mullooly, J. P., Thompson, R. S., & for the Vaccine Safety Datalink Team (2003) · PEDIATRICS · doi:10.1542/peds.112.4.815 · Cited by 320
Antibody Levels and Protection after Hepatitis B Vaccination: Results of a 15-Year Follow-up
McMahon, B. J., Bruden, D. L., Petersen, K. M., Bulkow, L. R., Parkinson, A. J., Nainan, O., Khristova, M., Zanis, C., Peters, H., & Margolis, H. S. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-5-200503010-00008 · Cited by 315
Chang, M.-H. (2007) · Seminars in Fetal and Neonatal Medicine · doi:10.1016/j.siny.2007.01.013 · Cited by 296
van Zonneveld, M., van Nunen, A. B., Niesters, H. G. M., de Man, R. A., Schalm, S. W., & Janssen, H. L. A. (2003) · Journal of Viral Hepatitis · doi:10.1046/j.1365-2893.2003.00440.x · Cited by 289
Hepatitis B Vaccine in Medical Staff of Hemodialysis Units: Efficacy and Subtype Cross-Protection
Szmuness, W., Stevens, C. E., Harley, E. J., Zang, E. A., Alter, H. J., Taylor, P. E., DE Vera, A., Chen, G. T. S., Kellner, A., & the Dialysis Vaccine Trial Study Group (1982) · New England Journal of Medicine · doi:10.1056/nejm198212093072403 · Cited by 262
LUNG CANCER AND SMOKING IN SWITZERLAND
(1965) · The Lancet · doi:10.1016/s0140-6736(65)91333-4 · Cited by 220
Goodman, Z. D. (2007) · Modern Pathology · doi:10.1038/modpathol.3800682 · Cited by 217
Immunization of Preterm and Low Birth Weight Infants
Saari, T. N., & and Committee on Infectious Diseases (2003) · Pediatrics · doi:10.1542/peds.112.1.193 · Cited by 215
Antibody to Human Immunodeficiency Virus (HIV) and Suboptimal Response to Hepatitis B Vaccination
Collier, A. C., Corey, L., Murphy, V. L., & Handsfield, H. H. (1988) · Annals of Internal Medicine · doi:10.7326/0003-4819-109-2-101 · Cited by 214
Crosnier, J., Jungers, P., Couroucé, A., Laplanche, A., Benhamou, E., Degos, F., Lacour, B., Prunet, P., Cerisier, Y., & Guesry, P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)92679-9 · Cited by 214
Hsu, H.-Y., Chang, M.-H., Ni, Y.-H., & Chen, H.-L. (2004) · Gut · doi:10.1136/gut.2003.034223 · Cited by 210
Lu, C., Ni, Y., Chiang, B., Chen, P., Chang, M., Chang, L., Su, I., Kuo, H., Huang, L., Chen, D., et al. (2008) · The Journal of Infectious Diseases · doi:10.1086/587695 · Cited by 198
Self-citationNew hepatitis B vaccine formulated with an improved adjuvant system
Kundi, M. (2007) · Expert Review of Vaccines · doi:10.1586/14760584.6.2.133 · Cited by 193
Crosnier, J., Jungers, P., Couroucé, A.-M., Laplanche, A., Benhamou, E., Degos, F., Lacour, B., Prunet, P., Cerisier, Y., & Guesry, P. (1981) · The Lancet · doi:10.1016/s0140-6736(81)91847-x · Cited by 163
Use of Combination Vaccines Is Associated With Improved Coverage Rates
Marshall, G. S., Happe, L. E., Lunacsek, O. E., Szymanski, M. D., Woods, C. R., Zahn, M., & Russell, A. (2007) · Pediatric Infectious Disease Journal · doi:10.1097/inf.0b013e31805d7f17 · Cited by 162
LEGIONNAIRES' DISEASE RELATED TO GASTRIC LAVAGE WITH TAP WATER
Dournon, E., Bure, A., Desplaces, N., Carette, M. F., & Mayaud, C. (1982) · The Lancet · doi:10.1016/s0140-6736(82)91837-2 · Cited by 161
Chang, M.-H., Chen, T. H.-H., Hsu, H.-M., Wu, T.-C., Kong, M.-S., Liang, D.-C., Ni, Y.-H., Chen, C.-J., Chen, D.-S., & for the Taiwan Childhood HCC Study Group (2005) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-05-1095 · Cited by 159
Self-citationHsu, H. M., Chen, D., Chuang, C. H., et al. (1988) · PubMed · Cited by 154
Self-citationIntegration of hepatitis B vaccination into national immunisation programmes
Damme, P. V., Kane, M. A., Meheus, A., & Meheus, A. (1997) · BMJ · doi:10.1136/bmj.314.7086.1033 · Cited by 149
Poovorawan, Y. (1989) · JAMA · doi:10.1001/jama.1989.03420220092033 · Cited by 147
Rottinghaus, S. T., Poland, G. A., Jacobson, R. M., Barr, L. J., & Roy, M. J. (2003) · Vaccine · doi:10.1016/s0264-410x(03)00447-x · Cited by 147
Long‐Term Immunogenicity and Efficacy of Universal Hepatitis B Virus Vaccination in Taiwan
Lin, Y., Chang, M., Ni, Y., Hsu, H., & Chen, D. (2002) · The Journal of Infectious Diseases · doi:10.1086/345871 · Cited by 141
Self-citationStevens, C. E., Toy, P. T. C. Y., Taylor, P. E., Lee, T., & Yip, H.-Y. (1992) · PEDIATRICS · doi:10.1542/peds.90.1.170 · Cited by 134
Ip, H. M. H., Wong, V. W., Lelie, P. N., Kuhns, M., & Reesink, H. W. (1989) · The Lancet · doi:10.1016/s0140-6736(89)90003-2 · Cited by 126
Dentinger, C., McMahon, B. J., Butler, J. C., Dunaway, C. E., Zanis, C. L., BULKOW, L. R., Bruden, D. L., Nainan, O. V., Khristova, M. L., Hennessy, T. W., et al. (2005) · The Pediatric Infectious Disease Journal · doi:10.1097/01.inf.0000176617.63457.9f · Cited by 126
Hepatitis A and B immunizations of individuals infected with human immunodeficiency virus
Laurence, J. C. (2005) · The American Journal of Medicine · doi:10.1016/j.amjmed.2005.07.024 · Cited by 124
Hsu, H., Lu, C., Lee, S.-C., Lin, S., & Chen, D. (1999) · The Journal of Infectious Diseases · doi:10.1086/314585 · Cited by 120
Self-citationResponse of preterm infants to hepatitis B vaccine
Lau, Y., Tam, A. Y. C., Ng, K. W., et al. (1992) · The Journal of Pediatrics · doi:10.1016/s0022-3476(05)80352-x · Cited by 119
Mele, A., Tancredi, F., Romanò, L., et al. (2001) · The Journal of Infectious Diseases · doi:10.1086/323396 · Cited by 115
Long-term Follow-up of Hepatitis B Vaccine in Infants of Carrier Mothers
Marion, S. A., Pastore, M. T., Pi, D., & Mathias, R. G. (1994) · American Journal of Epidemiology · doi:10.1093/oxfordjournals.aje.a117321 · Cited by 115
Chen, H., Chang, C., Kong, M., Huang, F., Lee, H., Lin, C., Liu, H., Lee, I.-H., Wu, T., Wu, S., et al. (2004) · Hepatology · doi:10.1002/hep.20006 · Cited by 113
Self-citationLee, S., Lo, K., Wu, J., Tsai, Y., Wang, J.-Y., Ting, L., & Tong, M. J. (1986) · Hepatology · doi:10.1002/hep.1840060306 · Cited by 110
Maternal transmission of hepatitis B virus in childhood hepatocellular carcinoma
Chang, M., Chen, D., Hsu, H., Hsu, H., & Lee, C. (1989) · Cancer · Cited by 110
Self-citationImpaired Response to Recombinant Hepatitis B Vaccine in HIV-Infected Persons
Bruguera, M., Cremades, M., Salinas, R., Costa, J. M., Grau, M., & Sans-Sabrafen, J. (1992) · Journal of Clinical Gastroenterology · doi:10.1097/00004836-199201000-00007 · Cited by 108
Kao, J., Hsu, H., Shau, W., Chang, M., & Chen, D. (2001) · The Journal of Pediatrics · doi:10.1067/mpd.2001.116277 · Cited by 103
Self-citationBoxall, E. H., Sira, J., El‐Shuhkri, N., et al. (2004) · The Journal of Infectious Diseases · doi:10.1086/423818 · Cited by 102
YUEN, M., Lim, W.-L., Chan, A. O.-O., Wong, D. K.-H., Sum, S. S., & Lai, C. (2004) · Clinical Gastroenterology and Hepatology · doi:10.1016/s1542-3565(04)00384-2 · Cited by 101
Wang, L. (2007) · Bulletin of the World Health Organization · doi:10.2471/blt.06.037002 · Cited by 101
Double-dose accelerated hepatitis B vaccine in patients with end-stage liver disease
Arslan, M., Wiesner, R. H., Sievers, C., et al. (2001) · Liver Transplantation · doi:10.1053/jlts.2001.23069 · Cited by 101
Charest, A. F., McDougall, J., & Goldstein, M. B. (2000) · American Journal of Kidney Diseases · doi:10.1053/ajkd.2000.19099 · Cited by 96
Hepatitis B Virus Infection, Its Sequelae, and Prevention in Taiwan
Chen, D. (1987) · Springer eBooks · doi:10.1007/978-4-431-68349-0_6 · Cited by 94
Self-citationFabrizi, F., Martin, P. B., Dixit, V., Bunnapradist, S., & Dulai, G. S. (2004) · Alimentary Pharmacology & Therapeutics · doi:10.1111/j.1365-2036.2004.02264.x · Cited by 91
Hepatitis B Vaccination and Hepatocellular Carcinoma in Taiwan
Lee, C.-L., & Ko, Y. (1997) · PEDIATRICS · doi:10.1542/peds.99.3.351 · Cited by 89
Impact of hepatitis B immunisation as part of the EPI
Poovorawan, Y., Theamboonlers, A., Vimolket, T., Sinlaparatsamee, S., Chaiear, K., Siraprapasiri, T., Khwanjaipanich, S., Owatanapanich, S., Hirsch, P., & Chunsuttiwat, S. (2000) · Vaccine · doi:10.1016/s0264-410x(00)00216-4 · Cited by 86
Ruff, T., Gertig, D. M., Otto, B., Gust, I. D., Sutanto, A., Soewarso, T. I., Kandun, N., Marschner, I. C., & Maynard, J. E. (1995) · The Journal of Infectious Diseases · doi:10.1093/infdis/171.2.290 · Cited by 82
Mele, A., Tosti, M. E., Mariano, A., Pizzuti, R., Ferro, A. M., Borrini, B. M., Zotti, C. M., Lopalco, P. L., Curtale, F., Balocchini, E., et al. (2008) · Clinical Infectious Diseases · doi:10.1086/528687 · Cited by 80
Vaccination against hepatitis B infection in patients with end stage renal disease
Bel'eed, K., Wright, M., Eadington, D. W., Farr, M., & Sellars, L. (2002) · Postgraduate Medical Journal · doi:10.1136/pmj.78.923.538 · Cited by 75
Failure of hepatitis B immunization in liver transplant recipients: results of a prospective trial.
Carey, W., Pimentel, R., Westveer, M. K., VOGT, D. P., & Broughan, T. A. (1990) · PubMed · Cited by 75
Lin, C. H., Chen, C.-L., Concejero, A. M., Wang, C., Wang, S.-H., Liu, Y., Yang, C., Yong, C., Lin, T., Jawan, B., et al. (2006) · American Journal of Transplantation · doi:10.1111/j.1600-6143.2006.01618.x · Cited by 73
Zuckerman, J. N., van Hattum, J., CAFFERKEY, M. T., et al. (2007) · The Lancet Infectious Diseases · doi:10.1016/s1473-3099(07)70136-6 · Cited by 73
Safety of immunization and adverse events following vaccination against hepatitis B
DUCLOS, P. J. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00153-3 · Cited by 71
Lee, C., Huang, L., Chang, M., Hsu, C.-Y., WU, S.-J., Sung, J., & Safary, A. (1991) · The Pediatric Infectious Disease Journal · doi:10.1097/00006454-199104000-00007 · Cited by 71
Impaired response to hepatitis B vaccine in HIV infected children
Zuin, G., Principi, N., TORNAGHI, R., Paccagnini, S., Re, M. C., MASSIRONI, E., & Ragni, M. C. (1992) · Vaccine · doi:10.1016/0264-410x(92)90050-t · Cited by 67
Lee, C., Hsieh, K., & Ko, Y. (2003) · PubMed · Cited by 65
da Motta, M. S. F., Mussi‐Pinhata, M. M., Jorge, S. M., et al. (2002) · Vaccine · doi:10.1016/s0264-410x(01)00493-5 · Cited by 64
Otto, B., Suarnawa, I. M., Stewart, T., et al. (1999) · Vaccine · doi:10.1016/s0264-410x(99)00242-x · Cited by 63
Improving birth dose coverage of hepatitis B vaccine
Hipgrave, D. B. (2004) · Bulletin of the World Health Organization · doi:10.2471/blt.04.017426 · Cited by 61
Milne, A., West, D. J., Chính, Đ. V., Moyes, C. D., & Poerschke, G. (2002) · Journal of Medical Virology · doi:10.1002/jmv.10071 · Cited by 58
Immunogenicity of hepatitis B vaccine in healthy very low birth weight infants
Patel, D. M., Butler, J., Feldman, S., Graves, G. R., & Rhodes, P. G. (1997) · The Journal of Pediatrics · doi:10.1016/s0022-3476(97)70078-7 · Cited by 57
Lolekha, S., Warachit, B., Hirunyachote, A., Bowonkiratikachorn, P., West, D. J., & Poerschke, G. (2002) · Vaccine · doi:10.1016/s0264-410x(02)00358-4 · Cited by 57
Mettang, T., Schenk, U., Thomas, S., Machleidt, C., Kiefer, T., Fischer, F.-P., & Kuhlmann, U. (2008) · The Nephron journals/Nephron journals · doi:10.1159/000188841 · Cited by 54
Hepatitis B vaccination for patients with chronic renal failure
Schroth, R. J., Hitchon, C. A., Uhanova, J., Noreddin, A. M., Taback, S. P., Moffatt, M. E. K., & Zacharias, J. (2004) · Cochrane Database of Systematic Reviews · doi:10.1002/14651858.cd003775.pub2 · Cited by 54
Heat stability of a recombinant DNA hepatitis B vaccine
Damme, P. V., Cramm, M., Safary, A., Vandepapelière, P., & Meheus, A. (1992) · Vaccine · doi:10.1016/0264-410x(92)90064-q · Cited by 51
Adult Hepatitis B Vaccination Using A Novel Triple Antigen Recombinant Vaccine
Young, M. D., Schneider, D. L., Zuckerman, A. J., Du, W., Dickson, B., & Maddrey, W. C. (2001) · Hepatology · doi:10.1053/jhep.2001.26167 · Cited by 48
Pichichero, M. E., Bernstein, H. H., Blatter, M. M., Schuerman, L., Cheuvart, B., & Holmes, S. J. (2007) · The Journal of Pediatrics · doi:10.1016/j.jpeds.2007.02.013 · Cited by 42
Paitoonpong, L., & Suankratay, C. (2007) · Scandinavian Journal of Infectious Diseases · doi:10.1080/00365540701522975 · Cited by 42
Impact of hepatitis B immunization, Europe and worldwide
Namgyal, P. (2003) · Journal of Hepatology · doi:10.1016/s0168-8278(03)00269-1 · Cited by 39
Bhimma, R., Coovadia, H. M., Adhikari, M., & Connolly, C. A. (2003) · Archives of Pediatrics and Adolescent Medicine · doi:10.1001/archpedi.157.10.1025 · Cited by 39
Assateerawatt, A., Tanphaichitr, V. S., Suvatte, V., et al. (1993) · PubMed · Cited by 34
Serological response to hepatitis B virus vaccine in HIV‐infected children in Tanzania
Pippi, F., Bracciale, L., Stolzuoli, L., Giaccherini, R., Montomoli, E., Gentile, C., Filetti, S., Luca, A. D., & Cellesi, C. (2008) · HIV Medicine · doi:10.1111/j.1468-1293.2008.00598.x · Cited by 34
Efficacy of repeated high‐dose hepatitis B vaccine (80 μg) in patients with chronic liver disease
Aziz, A., Aziz, S., Li, D. S., Murphy, L., Leone, N., Kennedy, M., Dhillon, S. S., & Thiel, D. H. V. (2005) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2005.00674.x · Cited by 33
Response to hepatitis B vaccine in preterm babies.
Sood, A., Singh, D., Mehta, S., et al. (2002) · PubMed · Cited by 28
PONGPIPAT, D., Suvatte, V., & Assateerawatts, A. (1989) · PubMed · Cited by 24
[Efficacy of hepatitis B vaccination on hepatitis B prevention and on hepatocellular carcinoma].
Li, R., Yang, J.-Y., Gong, J., Li, Y., Huang, Z.-N., Fang, K.-X., Xu, Z.-Y., Liu, C.-B., Zhao, K., & Zhuang, H. (2004) · PubMed · Cited by 23
Long-Term Protection of Hepatitis B Vaccine: Lessons from Alaskan Experience after 15 Years
Chen, D. (2005) · Annals of Internal Medicine · doi:10.7326/0003-4819-142-5-200503010-00014 · Cited by 21
Self-citationUniversal Hepatitis B Vaccination: Killing 2 Birds with 1 Stone
Kao, J., & Chen, D. (2008) · The American Journal of Medicine · doi:10.1016/j.amjmed.2008.09.002 · Cited by 12
Self-citation
Cited by
Tumor initiation and early tumorigenesis: molecular mechanisms and interventional targets
Zhang, S., Xiao, X., Yi, Y., Wang, X., Zhu, L., Shen, Y., Lin, D., & Wu, C. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01848-7 · Cited by 399
Zou, H., Chen, Y., Duan, Z., Zhang, H., & Pan, C. (2012) · Journal of Viral Hepatitis · doi:10.1111/j.1365-2893.2011.01492.x · Cited by 366
Pattyn, J., Hendrickx, G., Vorsters, A., & Van Damme, P. (2021) · The Journal of Infectious Diseases · doi:10.1093/infdis/jiaa668 · Cited by 282
Wen, W.-H., Chang, M.-H., Zhao, L.-L., Ni, Y.-H., Hsu, H.-Y., Wu, J.-F., Chen, P.-J., Chen, D.-S., & Chen, H.-L. (2013) · Journal of Hepatology · doi:10.1016/j.jhep.2013.02.015 · Cited by 267
Self-citationStrategies to control hepatitis B: Public policy, epidemiology, vaccine and drugs
Locarnini, S., Hatzakis, A., Chen, D.-S., & Lok, A. (2015) · Journal of Hepatology · doi:10.1016/j.jhep.2015.01.018 · Cited by 262
Self-citation
Metadata
- Authors
- Chen, D.-S.
- Venue
- Journal of Hepatology
- Publisher
- Elsevier BV
- Published
- 2009-04
- Volume
- 50
- Issue
- 4
- Pages
- 805-816
- ISSN
- 0168-8278 (ISSN-L)
- OpenAlex
- W2038452027
- Cited by
- 261
- References
- 97
- FWCI
- 12.13
- Type
- journal article
- Language
- en
- Open access
- hybrid
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.